Ergometrine

From NOWA-CL
Revision as of 02:34, 4 December 2024 by Admin (talk | contribs) (Created page with "{{Compound|aka=Ergonovine|chemf=C19H23N3O2|mm=325.41|density=|mp=150-152|bp=|sol_aq=|stp_p=|stp_q=|listed_dea=yes|medicine=yes|listed_who=yes|ld50=8.2mg/kg (mouse)}} ==Uses== ===Primary=== * Pharm: WHO LEM component ==Natural occurrence== * '''Does''' occur naturally in the growths of claviceps purpurea. ==Hazards== ==Production== ===Extraction=== ====from defatted ergot powder==== A general process to extract ergomerine from "defatted ergot powder" with a yield of...")
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search

Legality: DEA Listed Chemicals

Production of this substance may be illegal in some jurisdictions under certain circumstances.

21CFR1310.02 a & b

In 1995/6, two lists were created "List I" and "List II", for which commercial manufacturers and distributors must register, and for which possession with the intent to manufacture illegal substances (such as methamphetamine, ecstasy, etc) is illegal. On these a few dozen "precursor" compounds commonly used in the manufacture of illegal drugs. [1] [2]

Bottom line: Do not produce this chemical without checking to make sure that you may do so legally.

 
 
Ergometrine
aka Ergonovine
DEA LIST I/II SUBSTANCE
Chemical formula C19H23N3O2
Molar Mass(g/mol) 325.41 
Melting Point(°C) 150-152 
LD50 8.2mg/kg (mouse)
NFPA 704
NFPA704.png
0
0
0
 

Uses

Primary

  • Pharm: WHO LEM component

Natural occurrence

Hazards

Production

Extraction

from defatted ergot powder

A general process to extract ergomerine from "defatted ergot powder" with a yield of 0.82g ergometrine from 10kg of powder was published in 1935.[3]

  1. Initial Extraction into ergometrine sulfate(aq)
    1. Prepare "defatted ergot powder"
    2. Mix thoroughly with hot, dilute sulfuric acid
      Ergometrine(aq) -> ergometrine sulfate(aq)
    3. filter and discard residue (primarily undissolved organic material)
  2. Extract into ethanol and thence ergometrine(tcm)
    1. Basify with excess barium hydroxide
      ergometrine sulfate(aq) → ergometrine(aq)
    2. filter and discard residue (primarily barium sulfate)
    3. bubble carbon dioxide through the filtrate
    4. filter and discard residue (primarily barium carbonate)
    5. evaporate to "a small volume"
    6. add pure ethanol, resulting in a "sticky" precipitate
    7. filter and discard residue (sticky precipitate)
    8. Mix thoroughly with trichloromethane
      Ergometrine(aq) → Ergometrine(tcm)
    9. Separate and discard aqueous layer
  3. Extract into ergometrine sulfate(aq)
    1. Mix thoroughly with hot dilute sulfuric acid
      Ergometrine(tcm) -> ergometrine sulfate(aq)
    2. Separate and discard chloroform layer
  4. Extract into ergometrine (tcm)
    Basically repeating step 2 without the ethanol "throw down"
    1. Basify with excess barium hydroxide
      Ergometrine sulfate(aq) → ergometrine(aq)
    2. filter and discard residue (primarily barium sulfate)
    3. bubble carbon dioxide through the filtrate
    4. filter and discard residue (primarily barium carbonate)
    5. Mix thoroughly with trichloromethane
      Ergometrine(aq) → Ergometrine(tcm)
    6. Evaporate to dryness (resinous material containing ergometrine crystals
  5. Dissolve and remove resinous material
    1. Slowly and incrementally add trichloromethane sufficient to dissolve the resinous material, but leaving the less-soluble ergometrine crystals undissolved.
    2. Filter and discard filtrate
  6. Recrystallize from benzene

Preparations

  • Ergotamine maleate (ergotamine's salt with maleic acid is more stable than the free base, and is the usual injectable form
    In human medicine, it is used orally and parenterally in the prevention and treatment of postpartum

haemorrhage caused by uterine atony and for the stimulation of uterine involution. Usual oral doses are 500 μg 3 times daily up to 1.8 mg daily (approximately 0.03 mg/kg bw)

Testing

Purification

Recrystallize from trichloromethane, benzene or dichloroethylene, giving needle-like crystals

Storage

Disposal

See Also

References

  1. "Emphasizing the "Control" in controlled substances"
    United States Drug Enforcement Agency
    link last accessed 11 September 2012.
  2. "Controlled Substances Act; Title 21; Chapter 13; Subchapter I"
    United States Food & Drug Administration
    link last accessed 11 September 2012.
  3. Dudley, H. W.; Moir, Chassar (1935) "The Substance Responsible for the Traditional Clinical Effect of Ergot" (local copy)
    British Medical Journal 1(3871); pp520–523.. 
    link courtesy United States' National Library of Medicine.